Schedule of operating expenses (Details) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 31, 2024 |
|||
| Selling and marketing expenses: | |||||
| Total selling and marketing expenses | $ 12,991 | ||||
| General and administrative expenses: | |||||
| Share-based compensation | 1,050,350 | 436,800 | |||
| Audit fees | 321,711 | 354,800 | 305,000 | ||
| Attorney fee | 297,969 | 132,745 | 141,689 | ||
| Employee compensation and benefit | 157,717 | 475,579 | 277,725 | ||
| Rental fee | [1] | 112,632 | 103,133 | 169,961 | |
| Nasdaq annual listing and registrar fees | 90,202 | 70,516 | 66,655 | ||
| Consulting fees | 83,480 | 63,413 | 98,315 | ||
| Investment relationship fee | 49,129 | 9,129 | 41,990 | ||
| Depreciation expenses | 18,459 | 18,306 | 18,356 | ||
| Office expense | 11,320 | 62,974 | 33,492 | ||
| Entertainment | 1,515 | 1,661 | 906 | ||
| Amortization of intangible assets | 31,929 | ||||
| Credit losses on AR | 162,028 | ||||
| Others | 7,531 | 10,703 | 2,822 | ||
| General and administrative expenses | 2,202,015 | 1,739,759 | 1,350,868 | ||
| Research and development expenses: | |||||
| Total research and development expenses | 434,854 | ||||
| Operating expenses – Continuing operations | 2,649,860 | 1,739,759 | 1,350,868 | ||
| Operating expenses – Discontinued operations | $ 725,540 | $ 835,823 | |||
| |||||